期刊文献+

预注肌松药在全身麻醉下气管内插管术的应用 被引量:3

Application of different priming dose of muscle relaxant in endotracheal intubation and general an-esthesia
原文传递
导出
摘要 目的观察预注不同剂量肌松药在全身麻醉下气管内插管术的影响。方法ASAⅠ-Ⅱ级择期手术患者120例随机分为6组(n=20),分别为维库溴铵组(V1, V2, V3 )和顺式阿曲库铵组(C1, C2, C3),其中V1、C1为对照组,V2、V3、C2、C3为预注组。所有患者给予丙泊酚血浆TCI3μ∥ml,芬太尼3Cg/kg全麻诱导后,对照组:V1、C1分别静注2倍ED95剂量维库溴铵和3倍ED95剂量顺式阿曲库铵。预注组:V2、V3、C2、C3分别预注10、20μg/kg维库溴铵和15、30oμg/kg顺式阿曲库铵,待肌松起效后给予剩余的插管剂量肌松药。观察肌松起效时间(T1=0)、气管插管条件。结果6组的气管插管优良率均为100%。预注组V2、V3、C2、C3的起效时间(T1=0)明显缩短[(80.5±7.2)VS(146±10.7);(79.84-6.5)VS(1464-10.7);(138.5±7.2)VS(218±10.7);(127.1±6.5)VS(218±10.7)]。差异有统计学意义(P〈0.05)。结论预注不同剂量肌松药能显著缩短起效时间,加大预注量并不能进一步缩短肌松药的起效时间。 Objective To study the effects of different priming dose of muscle relaxant at the onset and endotracheal intubation conditions. Methods 120 ASA Ⅰ-Ⅱgrade patients were randomly divided into 6 groups ( n -6), vecuronium group ( V1, V2, V3 ) and cis-atracurium group ( C1, C2, C3 ). All patients were induced with propofol plasma (TCI)3 tLg/ml,fentanil3 trg/kg. The Vt and C1 group were not givenpriming dose, and the V2, V3, C2, C3 groups were given priming dose of 10 μg/kg,20μg/kg vecuronium and 15 μg/kg,30 μg/kg cis-atracurium. Intubating conditions were evaluated, and the onset time was mo- nitored with train-of-four (TOF) technique. Results Intubating conditions were excellent in all patients. The onset time of priming groups of the four different doses was significantly shorter than that of the nonprim- ing group [(80.5 ±7.2) vs (146±10.7);(79.8±6.5) vs (146±10.7);(138.5±7.2) vs (218± 10. 7 ) ; ( 127. 1 ± 6. 5) vs (218 ± 10. 7), P 〈 0. 05 ]. Conclusions The taking-effect time of priming dose of muscle relaxant was significantly shorter than that of the nonpriming dose group. Increasing the priming dose not decrease onset time more than the smaller dose.
出处 《中国医师杂志》 CAS 2012年第2期185-187,共3页 Journal of Chinese Physician
关键词 神经肌肉非去极药/投药和剂量 麻醉 全身 插管法 气管内 Neuromuscular nondepolarizing agents/AD Anesthesia, general Intubation,intratra-cheal
  • 相关文献

参考文献5

二级参考文献51

  • 1周志宏,徐建国.经蝶窦入路垂体瘤切除的麻醉处理[J].中华麻醉学杂志,1993,13(6):455-456. 被引量:1
  • 2Lowenick CV,Krampfl K,Schneck H,et al.Open channel and competitive block of nicotinic receptors by pancuronium and atracurium[J].Eur J Pharmacol,2001,413(1):31-35.
  • 3Downie DL,Franks NP,Lieb WR.Effects of thiopental and its optical isomers on nicotinic acetylcholine receptors[J].Anesthesiology,2000,93(3):774-783.
  • 4Dilger JP,Vidal AM,Liu M,et al.Roles of amino acids and subunits in determining the inhibition of nicotinic acetylcholine receptors by competitive antagonists[J].Anesthesiology,2007,106(6):1186-1195.
  • 5Purohit PG,Tate RJ,Pow E,et al.The role of the amino acid residue at a 1:189 in the binding of neuromuscular blocking agents to mouse and human muscle nicotinic acetylcholine receptoes[J].Bri J Pharmacology,2007,150(10):920-931.
  • 6Deeptankar D,James PD.The kinetics of competitive antagonism by cisatracurium of embryonic and adult nicotinic acetylcholine receptors[J].Mol Pharmacol,2001,60(7):797-807.
  • 7Jahn K,Mohammadi B,Kramplf K,et al.Deactivation and desensitization of mouse embryonic-and adult-type nicotinic receptor channel currents[J].Neuroscience Letters,2001,307(1):89-92.
  • 8Jonsson Fagerlund M,Dabrowski M,Eriksson LI.Pharmacological characteristics of the inhibition of nondepolarizing neuromuscular blocking agents at human adult muscle nicotinic acetylcholine receptor[J].Anesthesiology,2009,110(6):1244-1252.
  • 9薛福善 郭英 王恩真 薛福善 主编.肌松药在神经外科麻醉中的应用 [A].王恩真,薛福善, 主编.神经外科麻醉学第1版 [M].北京: 人民卫生出版社,2000.335-336.
  • 10Miller RD. Anesthesia [M]. 4th edition. New York: Churchill Livingstone Ine, 1994: 431-433.

共引文献57

同被引文献31

  • 1Schmidt J, Albrecht S, Petterich N, et al. Priming technique with cisatracurium onset time at the laryngeal muscles - J ]. Anaes- thesist,2007,56(10) :992-1000.
  • 2Langeron O, Amour J, Vivien B, et al. Clinical review : man- agement of difficult airways - J 1- Crit Care, 2006,10 : 243-249.
  • 3Lin SP, Chang KY, Chen YJ, et al. Priming with rocuronium to accelerate the onset time of cisatracudum during intubation [ J]. J Chin Med Assoc,2009,72( 1 ) :15-19.
  • 4Melloni C, Devivo P, Launo C, et al. Cisatracurium versus ve- curonium: a comparative, double blind, randomized, multi- center study in adult patients under propofol/fentanyl/N20 anesthesia[ J]. Minerva Anestesio1,2006,72 ( 5 ) :299-308.
  • 5Lin SK, Chang KY, Chen YJ, et al. Priming with rocuronium to Accelerate the onset time of cisatracurium during intobation E J 1. J Chin Med Assoc ,2009,2 ( l ) : 15-19.
  • 6Dong YJ,Li X. Comparative study on the pharmacodynamics of cisatracurium: continuous infusion or intermittent bolus in- jection[ J]. Contemp Clin Trials ,2012,33 ( 3 ) :482-485.
  • 7Esteves S ,Martins M, Barros F, et al. incidence of postopera- tive residual neuromuscular blockade in the postanaesthesia care unit an observational multicentre study in Portugal [ J ]. Eur J Anaesthesiol,2013,30(5) :243-249.
  • 8查燕萍,李金宝,邓小明.罗库溴铵和顺式阿曲库铵用于全麻诱导气管插管的效果比较[J].第二军医大学学报,2009,30(8):903-906. 被引量:8
  • 9雷钟,段惠洁,钟唯一.咪达唑仑、异丙酚、芬太尼联合诱导气管插管对血流动力学的影响[J].新疆医科大学学报,2009,32(8):1165-1167. 被引量:3
  • 10马荣华,杨拔贤.肌松药残余作用的评估与拮抗[J].中国医药,2010,5(3):284-286. 被引量:7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部